** Shares of medical device maker Teleflex TFX.N fall 5.9% to $119.12 premarket
** Co cuts revenue forecast for 2025 to $3.270 billion to $3.278 billion vs. previous forecast of $3.305 billion to $3.320 billion
** Analysts were expecting a revenue of $3.32 billion - LSEG data
** Co says reduction is principally the result of softer-than-expected year-end demand for intra-aortic balloon pumps and catheters in the U.S. and Asia and delays in certain purchase orders in the OEM business
** Appoints Stuart Randle as interim CEO, effective immediately
** Randle succeeds Liam Kelly, who departs as Chairman, President and CEO
** As of last close, stock down 28.9% in the past 12 months
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))